3SOF

It hit the former break out level and 9-day so usually a good buy point http://tinyurl.com/zrps4

Ok I admit I am not much of a technical guy.  I usually just eye-ball charts but here's the problem.  This stock had great earnings, then profit taking yestreday.  However look at what happened today.  It gapped down... not only that it went down from there.  I think there's a lot of reason to be cautious on this one now.

update AOB:

AOB gapped down and put in a nice high wave candle(long shadows small body in the middle).  Potentially setting us up for a bullish island reversal.  The market has been tough on our long plays but we will give AOB a bit of room by putting in a stop just below the 20ema.

------
Position: bought AOB @ 6.00 on 05/16/2006
Order: Hold
Exit: stop @ 5.20
Target: n/a
------

hi,
the battle is at 5.74  bulls and bears. who will win?

update AOB:

AOB closed with a nice sign of support on Monday.  Volume increased and we saw some downward price rejection and a 20ema pierce(a bullish sign).  Just missed our stop by 5cents and now ready to head higher.

------
Position: bought AOB @ 6.00 on 05/16/2006
Order: Hold
Exit: stop @ 5.20
------

fyi:
AOB: Short Interest DN 10.8% to 539.5K in May 2006
Friday , May 19, 2006 16:00 ET

According to new short interest data from AMEX, short interest for American Oriental Bioengineering Inc (AMEX: AOB) DECREASED 10.8% to 539,500 shares for the month ended mid-May, 2006.

SYMBOL         APRIL             MAY          CHANGE       %CHANGE      DAYS/COVER
--------   -------------   -------------   -------------  ------------  ----------
AOB              605,071         539,500         -65,571       -10.84%           1

Based on AOB's 20-day average daily share volume of 1,323,245, it would require approximately 1 day(s) of buying to cover this short interest.

updated AOB analysis, please check my attached pdf file !!!

nice chart action today 

American Oriental Bioengineering, Inc. Provides Update on the Acquisition of Guangxi Lingfeng Pharmaceutical
Thursday July 13, 9:30 am ET

HONG KONG--(BUSINESS WIRE)--July 13, 2006--American Oriental Bioengineering, Inc. (AMEX: AOB - News):

    * Marketing Initiatives in Place to Improve Sales
    * Synergies Identified to Expand GLP Margins
    * AOB Engages Ms. Ni Ping as Company Spokesperson
    * Acquisition Expected to Positively Contribute to 2Q06 and Full Year 2006; Revenues, Net Income and EPS

American Oriental Bioengineering, Inc. (AMEX: AOB - News), a leading manufacturer and distributor of pharmaceutical and nutraceutical products in China, provides update on the acquisition of Guangxi Lingfeng Pharmaceutical Company Limited (GLP). GLP is a manufacturer of plant-based pharmaceutical products in China, specializing in pediatrics, gynecopathy and medicines for the treatment of digestive and respiratory system illnesses.

"We are pleased to report that the integration of GLP has been progressing according to plan and we believe we have identified several areas where we can improve sales and reduce expenses to drive higher overall efficiency," commented Tony Liu, Chairman and Chief Executive Officer. "Similar to our acquisition of HSPL in September of 2004, where we improved sales by more than 300 percent and gross margins by nearly 20 percent in just over 12 months from the closing, we intend to create incremental value from our acquisition of GLP."

The acquisition of GLP has significantly expanded the plant based product (PBP) portfolio of AOB, contributing 70 potential products to the Company's existing PBP product offering. The acquisition of GLP has also increased AOB's points of distribution, particularly in Southern China, which has enabled the Company to better leverage its entire portfolio of PBP and plant based nutraceutical (PBN) products. GLP's flagship products, known as the Jinji Series, treat gynecological inflammations, such as endometritis and annexitis and are complementary to AOB's Cease Enuresis products for the treatment of bedwetting and nighttime urination.

In an effort to take advantage of its robust product portfolio, AOB has retained Ms. Ni Ping as the Company's official spokesperson. Ms. Ni Ping is a well known actor and television host within China, for her role in "Variety Wonderland", a primetime weekend special airing since 1990 and as the host of "Spring Festival Evening Party" which is estimated to have attracted more than one billion cumulative viewers during her tenure. With a now dedicated marketing budget, available resources and AOB's operational expertise, management's strategy is to improve GLP sales and profits from current levels.

"During the second quarter we will recognize over two months of contribution from GLP and expect the business to positively impact our reported results," Mr. Liu added. "Furthermore, I look forward to updating investors on our progress during our second quarter earnings conference call in August."

Moving up in anticipation of earnings on Monday.  Low today on 200ma and break above 50ma.  Terliso's 3 magics are right underneath.   This ran about 20% after May earnings were reported and there is certainly the potential for a repeat next week.

fyi:

American Oriental Bioengineering, Inc. Announces Strong Fourth Quarter Orders for GLP Products
Wednesday September 27, 8:58 am ET
-- As of September 24, the Company has received over $6 million in Initial Orders for GLP's Jinji Series of Products for the Fourth Quarter
-- The Company Anticipates a further Increase in Order Momentum for GLP Products

NEW YORK--(BUSINESS WIRE)--American Oriental Bioengineering, Inc. (AMEX: AOB - News), a leading manufacturer and distributor of plant-based pharmaceutical and nutraceutical products in China, today announced GLP has received over $6.0 million in orders for its Jinji Series of products which are expected to be delivered during the fourth quarter.


By leveraging AOB's marketing methodologies, its expanded distribution points and new advertising and marketing campaigns, AOB has begun to see an accelerating pace of business for GLP products. Specifically, the Company hired Ms. Ni Ping, a well known and recognized Chinese celebrity to endorse the Jinji Series of products which targets women's health. Additionally, AOB has implemented a comprehensive training program geared to further educating GLP salespeople and improving the overall level of sales execution. GLP's position in the market is strengthening as the products now have nationwide access to China through AOB's 100,000 distribution points.

"We are very pleased to see a further increase in revenue from our integration of GLP since April," commented Mr. Tony Liu, Chairman and Chief Executive Officer of AOB. "This level of order activity prior to the start of a quarter represents a record for GLP and we are comfortable with our manufacturing capacity to address further anticipated revenue growth. Strong demand for the products has necessitated AOB to manufacture during the China National Day Holiday, a time when many facilities are closed. We remain committed to establishing the Jinji Series as a top three brand in women's health in China and having the brand contribute significantly to AOB's total revenue."

nice AOB chart action....

Michael,
any update from your side ?

cheers
O.

 
anyone know why this stock is jumping, I am in at 5.03 and very happy I have held on through the last bit.   

any ideas what the future looks like --- are all the synergies finally starting to come together?

still climbing 

anybody else except of bw6458 holding this stock?

cheers
O.

Hi la-onda,

I'm also still holding. Still climbing, only $ 0,83 away from one year high. Looking very good. Wonder what's up? Any ideas?

Good luck,
Amarens

ps: Sorry, uploading charts is not working from the laptop I'm on.